SM-102

SM-102


SM-102 is a synthetic ionizable lipid which is used in combination with other lipids to form lipid nanoparticles (LNP) for drug delivery. These are used for the delivery of mRNA-based COVID-19 vaccines. The pKa is 6.68. Reagent grade, for research purpose.

Molecular structure of the compound BP-25499
    • Unit
    • Price
    • Qty
    • 50 MG
    • $280.00
    • 100 MG
    • $400.00
    • 250 MG
    • $850.00
    • 1 G
    • $1370.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire

Product Citations



  1. https://pubs.acs.org/doi/full/10.1021/acs.molpharmaceut.5c00614
  2. Amrit Raj Ghosh et al. ,Rapidly acquired HIV-1 neutralization breadth in a rhesus V2 apex knockin mouse model after a single bolus immunization.Sci. Immunol.11,eadz5064(2026).
    https://www.science.org/doi/10.1126/sciimmunol.adz5064
  3. Banda, O., Adams, S. E., Omer, L., Jung, S. K., Said, H., Phoka, T., ... & Kurre, P. (2025). Restoring hematopoietic stem and progenitor cell function in Fancc−/− mice by in situ delivery of RNA lipid nanoparticles. Molecular Therapy Nucleic Acids, 36(1).
    https://www.cell.com/molecular-therapy-family/nucleic-acids/fulltext/S2162-2531(24)00310-X
  4. Basham, C., Haney, M., Zhao, Y., Lukyanov, K. A., Kim, K., Baysal, A., ... & Ramsey, J. D. (2025). PEG-Free Tunable Poly (2-Oxazoline) Lipids Modulate LNP Biodistribution and Expression In Vivo after Intramuscular Administration. bioRxiv, 2025-06.
    https://www.biorxiv.org/content/10.1101/2025.06.05.657891v1.full
  5. Bhagchandani, S. H., Ehrenzeller, S., Pires, I. S., Chaudhary, N., Booth, C. J., Guedes de Sá, K. S., ... & Iwasaki, A. (2025). Bioactive Enhanced Adjuvant Chemokine Oligonucleotide Nanoparticles (BEACONs) for Mucosal Vaccination Against Genital Herpes. bioRxiv, 2025-07.
    https://www.biorxiv.org/content/10.1101/2025.07.31.667899v1.full
  6. Bhattacharya, A., Jan, L., Burlak, O., Li, J., Upadhyay, G., Williams, K., ... & Dey, A. K. (2024). Potent and long-lasting humoral and cellular immunity against varicella zoster virus induced by mRNA-LNP vaccine. npj Vaccines, 9(1), 72.
    https://www.nature.com/articles/s41541-024-00865-5
  7. Binici, B., Borah, A., Watts, J. A., McLoughlin, D., & Perrie, Y. (2025). The influence of citrate buffer molarity on mRNA-LNPs: Exploring factors beyond general critical quality attributes. International Journal of Pharmaceutics, 668, 124942.
    https://doi.org/10.1016/j.ijpharm.2024.124942
  8. Binici, B., Rattray, Z., Schroeder, A., & Perrie, Y. (2024). The role of biological sex in pre-clinical (mouse) mRNA vaccine studies. Vaccines, 12(3), 282.
    https://doi.org/10.3390/vaccines12030282
  9. Borah, A., Giacobbo, V., Binici, B., Baillie, R., & Perrie, Y. (2025). From in vitro to in Vivo: The Dominant role of PEG-Lipids in LNP performance. European Journal of Pharmaceutics and Biopharmaceutics, 114726.
    https://doi.org/10.1016/j.ejpb.2025.114726
  10. Borah, A., Giacobbo, V., Binici, B., Baillie, R., & Perrie, Y. (2025). From in vitro to in vivo: The Dominant role of PEG-Lipids in LNP performance. European Journal of Pharmaceutics and Biopharmaceutics, 114726.
    https://www.sciencedirect.com/science/article/pii/S0939641125001031
  11. Buckley, M., Arainga, M., Maiorino, L., Pires, I. S., Kim, B. J., Kaczmarek Michaels, K., ... & Irvine, D. J. (2024). Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates. bioRxiv, 2024-06.
    https://doi.org/10.1101/2024.06.21.600088
  12. Cataldi, V.; Chakraborty, S.; Alani, A. W. G. An Ultrasensitive Luciferase Reporter Reveals Low-Level Extrahepatic mRNA Expression for Enhanced Apparent Biodistribution of Lipid Nanoparticles. 2026.
    https://doi.org/10.64898/2026.09.15.751785
  13. Chaudhari, A. P.; Khosravi, P.; Tabashsum, Z.; Hensley, H. E.; Wang, C. J.; Moses, E. A.; Harris, S.; Hazelton, A.; Tiwade, P. B.; VanKeulen‐Miller, R.; Fenton, O. S.; Sheiko, S. S.; Rowe, S. E.; Nguyen, J. Shelf‐Stable, Ready‐To‐Use Therapeutic Patches: Dip‐And‐Deliver Solutions for Personalized Wound Care. Bioengineering & Translational Medicine 2026.
    https://doi.org/10.1002/btm2.70131
  14. Coleman, H. J., Rauch, A., Langsfeld, E., Anderson, K., Parlikar, U., Funke, H. H., ... & Randolph, T. W. (2025). Lipid-free, thermostable mRNA vaccines prepared using atomic layer deposition. Journal of Pharmaceutical Sciences, 104066.
    https://www.sciencedirect.com/science/article/abs/pii/S0022354925005209
  15. Coussens, E. Exploring the potential of CRISPR/Cas9 lipid nanoparticles to cure HIV.
    https://lib.ugent.be/catalog/rug01:003212736
  16. Cryer, A. M., Dosta, P., Dion, M. Z., de la Parra Soto, L., Amar-Lewis, E., Garcia de Leon Carmona, G., ... & Artzi, N. (2025). Restoration of cGAS in cancer cells promotes antitumor immunity via transfer of cancer cell–generated cGAMP. Proceedings of the National Academy of Sciences, 122(45), e2409556122.
    https://www.pnas.org/doi/abs/10.1073/pnas.2409556122
  17. Cui, Y.; Phuong, K.; Temple, H.; Wisdom, A. J.; Abdelfattah, N. S.; Spranger, S.; White, F. Analysis of Tumor-Derived and Cross-Presented Peptide Antigens Defines Improved Immunotherapeutic Strategies. 2026.
    https://doi.org/10.64898/2026.02.23.707477
  18. De Peña, A. C., Zimmer, D., Gutterman-Johns, E., Chen, N. M., Tripathi, A., & Bailey-Hytholt, C. M. (2024). Electrophoretic Microfluidic Characterization of mRNA-and pDNA-Loaded Lipid Nanoparticles. ACS Applied Materials & Interfaces.
    https://pubs.acs.org/doi/abs/10.1021/acsami.4c00208
  19. Edmonds, K. K., Wilkinson, M. E., Strebinger, D., Chen, H., Lash, B., Schaefer, C. C., ... & Zhang, F. (2025). Structure and biochemistry-guided engineering of an all-RNA system for DNA insertion with R2 retrotransposons. Nature Communications, 16(1), 6079.
    https://www.nature.com/articles/s41467-025-61321-z
  20. Edmonds, K. K., Wilkinson, M. E., Strebinger, D., Chen, H., Lash, B., Schaefer, C. C., Zhu, S., Liu, D., Zilberzwige-Tal, S., Ladha, A., Walsh, M. L., Frangieh, C. J., Vaz Reay, N. A., Macrae, R. K., Wang, X., & Zhang, F. (2025). Structure and biochemistry-guided engineering of an all-RNA system for DNA insertion with R2 retrotransposons. Nature communications, 16(1), 6079
    https://doi.org/10.1038/s41467-025-61321-z
  21. Eisenlohr, L.; Carro, S.; Hedgepeth, E.; Lucero-Sanchez, C.; Heard, M.; Corrigan, A.; Shin, H.; Peauroi, E. Conditional T and NK Cell Antagonism by a Giant and Highly Conserved Orthopoxvirus Virulence Factor. 2026.
    https://doi.org/10.21203/rs.3.rs-8672980/v1
  22. Eric Andrew Appel, Emily Louise MEANY, Shih Hao Ou. Compositions and methods for delivery of nucleic acid therapeutics. (WO2025035015A1)
    https://patents.google.com/patent/WO2025035015A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=10
  23. Evdokimou, M.; Alaqabani, H.; Hussain, M.; Perrie, Y. Incorporating Immunostimulatory Lipids Into Lipid Nanoparticles: Exploring Expression and Immune Responses. European Journal of Pharmaceutics and Biopharmaceutics 2026, 223, 115034.
    https://doi.org/10.1016/j.ejpb.2026.115034
  24. Fairlamb, M., Kumru, O. S., Hickey, J. M., Elbaz, N. M., Bevernaegie, R., Vander Straten, A., ... & Volkin, D. B. (2025). Developability assessments with four mRNA-LNP vaccine formulations comparing mouse immunogenicity, structural attributes, and stability profiles. VeriXiv, 2(275), 275.
    https://verixiv.org/articles/2-275/v1?src=rss
  25. Farzani, T.; Espinoza, N.; Manafi, M. M.; Welch, S. R.; Coleman-McCray, J. D.; Aida-Ficken, V.; Spengler, J. R.; Bergeron, É.; Spiropoulou, C. F.; Borges, C.; Bielecki, K.; Li, L.; Shah, D.; Paye, M.; Rojas, E.; Spector, S. N.; Samani, P.; Hensley, L. E.; Ozonoff, A.; Sabeti, P. C. A Modular MRNA–LNP Vaccine Platform Enables Integrated RNA, Lipid and Antigen Design to Protect against CCHFV. 2026.
    https://doi.org/10.64898/2026.01.17.699915
  26. Felgner, J., Hernandez-Davies, J. E., Strahsburger, E., Silzel, E., Nakajima, R., Jain, A., ... & Liang, L. (2025). Lipid Nanoparticle Development for A Fluvid mRNA Vaccine Targeting Seasonal Influenza and SARS-CoV-2. npj Vaccines, 10(1), 123.
    https://www.nature.com/articles/s41541-025-01153-6
  27. Felgner, J., Hernandez-Davies, J.E., Strahsburger, E. et al. Lipid Nanoparticle Development for A Fluvid mRNA Vaccine Targeting Seasonal Influenza and SARS-CoV-2. npj Vaccines 10, 123 (2025)
    https://doi.org/10.1038/s41541-025-01153-6
  28. Fonseca, R.; P. L. Coutinho, J.; Henriques, C.; Bastos, F.; Simões, S.; Reis, M.; Bernardo, F. Modeling of Lipid Nanoparticle Formation in Microuidic Mixers Using Computational Fluid Dynamics and Population Balance Equations, 2026.
    https://doi.org/10.2139/ssrn.7266146
  29. Forrester, J., Davidson, C. G., Blair, M., Donlon, L., McLoughlin, D. M., Obiora, C. R., ... & Perrie, Y. (2025). Low-cost microfluidic mixers: are they up to the task?. Pharmaceutics, 17(5), 566.
    https://www.mdpi.com/1999-4923/17/5/566
  30. Forrester, J., Davidson, C. G., Blair, M., Donlon, L., McLoughlin, D. M., Obiora, C. R., ... & Perrie, Y. (2025). Low-cost microfluidic mixers: are they up to the task?. Pharmaceutics, 17(5), 566.
    https://www.mdpi.com/1999-4923/17/5/566
  31. Ghosh, A. R., Habib, R., Mishra, N., Roark, R. S., Akauliya, M., Albowaidey, A. A., ... & Batista, F. D. (2025). Rapid acquisition of HIV-1 neutralization breadth in a rhesus V2 apex germline antibody mouse model after a single bolus immunization. bioRxiv, 2025-06.
    https://www.biorxiv.org/content/10.1101/2025.06.12.659380v1.full
  32. Giacobbo, V. (2025). End-to-end optimization of lipid nanoparticle manufacturing for mRNA delivery.
    https://stax.strath.ac.uk/concern/theses/vx021f609
  33. Grundler, J.; Chertok, B.; Nilam, A.; Edmundson, A.; Song, M.; Newton, M.; Scholfield, M. R.; Padilla, A. M.; Payton, N. M. Bleb Formation Induced by Acidic Mixing Buffers Improves Liquid Stability of MRNA-LNPs. 2026.
    https://doi.org/10.64898/2026.03.05.709631
  34. Ha, M.; Kim, J.; Kim, S.; Naidu, G. S.; Cho, S.; Yong, S. B. Immune Checkpoint Inhibitor as a Fifth Component of Lipid Nanoparticles Enables Lymph Node‐Targeting and Augments mRNA Vaccine Efficacy. Advanced Science 2026.
    https://doi.org/10.1002/advs.77923
  35. Harinck, L.; De Munter, S.; De Velder, M.; Ingels, J.; Berdecka, D.; Lentacker, I.; De Vos, W. H.; Vandekerckhove, B.; Braeckmans, K.; Raemdonck, K. Cationic MRNA Lipid Nanoparticles for Ex Vivo NanoCAR‐T Cell Engineering. Advanced Science 2026, 13 (24).
    https://doi.org/10.1002/advs.202521507
  36. Heiser, B. J., Lewis, M. M., Zerankeshi, M. M., Netemeyer, E. K., Hernandez, A. M., Marras, A. E., & Ghosh, D. (2025). Systematic screening of excipients to stabilize aerosolized lipid nanoparticles for enhanced mRNA delivery. RSC pharmaceutics.
    https://pubs.rsc.org/en/content/articlehtml/2025/pm/d5pm00061k
  37. Hołubowicz, R., Du, S. W., Felgner, J., Smidak, R., Choi, E. H., Palczewska, G., ... & Palczewski, K. (2024). Safer and efficient base editing and prime editing via ribonucleoproteins delivered through optimized lipid-nanoparticle formulations. Nature Biomedical Engineering, 1-22.
    https://www.nature.com/articles/s41551-024-01296-2
  38. Hu, Z.; Shi, L.; Lin, X.; Zhang, Q.; Zhang, Y.; You, F.; Chen, J.; Wang, H.; Ye, Y.; Chen, J.; Deng, W.; Deng, G. Effect of Low Glucose on MRNA Delivery Efficiency via Lipid Nanoparticles and Its Underlying Mechanisms. Molecular Pharmaceutics 2026, 23 (3), 2050–2063.
    https://doi.org/10.1021/acs.molpharmaceut.5c01780
  39. Hussain, M., Binici, B., O’Connor, L., & Perrie, Y. (2024). Production of mRNA lipid nanoparticles using advanced crossflow micromixing. Journal of Pharmacy and Pharmacology, 76(12), 1572-1583.
    https://academic.oup.com/jpp/article/76/12/1572/7816331
  40. Hussain, M., Ferguson-Ugorenko, A., Macfarlane, R., Orr, N., Clarke, S., Wilkinson, M. J., ... & Perrie, Y. (2025). Mind the age gap: expanding the age window for mRNA vaccine testing in mice. Vaccines, 13(4), 370.
    https://www.mdpi.com/2076-393X/13/4/370
  41. Hussain, M., Muglikar, A., Brain, D. E., Plant-Hately, A., Liptrott, N., McLoughlin, D. M., & Perrie, Y. (2025). Redefining LNP composition: phospholipid and sterol-driven modulation of mRNA expression and immune outcomes. RSC Pharmaceutics.
    https://pubs.rsc.org/en/content/articlehtml/2025/pm/d5pm00150a
  42. Jain, M.; Est-Witte, S. E.; Shannon, S. R.; Neshat, S. Y.; Yu, X.; Dunham, S.; Tian, T.; Cheng, L.; Harris, J.; Konig, M. F.; Tzeng, S. Y.; Schneck, J. P.; Green, J. J. Biodegradable Targeted Polymeric MRNA Nanoparticles Enable in Vivo CD19 CAR T Cell Generation and Lead to B Cell Depletion. Science advances 2026, 12 (11), eadz1722.
    https://doi.org/10.1126/sciadv.adz1722
  43. Jakub GOŁĄB, Dominika Nowis, Joanna Kowalska, Jacek Jemielity, Piotr SKLEPKIEWICZ, Mirosław ŚMIETAŃSKI, Olga SOKOŁOWSKA, Paweł Turowski, Hanna KĘDZIERSKA, Marek Baranowski, Tomasz ŚPIEWLA, Agnieszka Popielec. Modified rna for the treatment of cfdna-associated diseases. (WO2025176838A1)
    https://patents.google.com/patent/WO2025176838A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=2
  44. Jalil, S., Keskinen, T., Juutila, J., Maldonado, R. S., Euro, L., Suomalainen, A., ... & Wartiovaara, K. (2024). Genetic and functional correction of argininosuccinate lyase deficiency using CRISPR adenine base editors. The American Journal of Human Genetics, 111(4), 714-728.
    https://www.cell.com/ajhg/fulltext/S0002-9297(24)00077-6
  45. Jalili, S., Hosn, R. R., Ko, W. C., Afshari, K., Dhinakaran, A. K., Chaudhary, N., ... & Irvine, D. J. (2025). Leveraging tissue-resident memory T cells for non-invasive immune monitoring via microneedle skin patches. medRxiv, 2025-03.
    https://doi.org/10.1101/2025.03.17.25324099
  46. Jeon, J. H., Zhu, H., Qin, J., Wang, L., Mou, S., Langston, L. K., ... & Cui, X. (2025). Lipid Nanoparticles Formulated with a Novel Cholesterol-Tailed Ionizable Lipid Markedly Increase mRNA Delivery Both in vitro and in vivo. International Journal of Nanomedicine, 9389-9405.
    https://www.tandfonline.com/doi/full/10.2147/IJN.S527822
  47. Kang, J.; Shin, Y.; Kim, Y.-M.; Choi, J.-K.; Mun, J. Y.; Kim, J.; Beshchasna, N.; Yeo, J.-S. Surface Optimization of PMMA via Oxygen Plasma and APTES for Antibody Immobilization. Surface Innovations 2026, 14 (2), 72–80.
    https://doi.org/10.1680/jsuin.25.00036
  48. Kannan, R., Tran, B., Le, Q., Hohenwarter, L., Chao, P. H., Brar, V., ... & Li, S. D. (2025). Incorporation of a polyamine into lipid nanoparticles increases the endosomal release and transfection of nucleic acids without toxicity. Journal of Controlled Release, 114366.
    https://www.sciencedirect.com/science/article/pii/S0168365925009800
  49. Keskinen, T., Jalil, S., Gümüşoğlu, I., Juutila, J., Kestilä, N., Kuuluvainen, E., ... & Hyvönen, M. E. (2026). Genetic Correction of the Most Common Mutation Causing Primary Hyperoxaluria Restores Enzyme Localization and Oxalate Metabolism. Journal of Inherited Metabolic Disease, 49(1), e70122.
    https://onlinelibrary.wiley.com/doi/full/10.1002/jimd.70122
  50. Khalifeh, M., Oude Egberink, R., Roverts, R., & Brock, R. (2025). Incorporation of ionizable lipids into the outer shell of lipid-coated calcium phosphate nanoparticles boosts cellular mRNA delivery. International Journal of Pharmaceutics, 670, 125109.
    https://www.sciencedirect.com/science/article/pii/S0378517324013437
  51. Kim, J. G.; Xu, J.; Lee, D.; Song, J.; Lee, S.; Hong, M. H.; Zhu, J.; Zhu, A.; Patwari, K.; Shim, E.; Shin, J. E.; Park, O. H.; Rho, J.; Ko, K.-C.; Lee, E. G.; Kang, O.-Y.; Won, E.-J.; Kim, B. H.; Jang, J.-P.; Jang, J.-H. Comprehensive Engineering of Ionizable Lipid Nanoparticles and MRNA Elements for Next-Generation Vaccines. ACS Nano 2026, 20 (8), 7022–7045.
    https://doi.org/10.1021/acsnano.5c19036
  52. Kim, S. C., Felgner, J., Soto, M. S., Hitchcock, L., Silzel, E. K., Beares, H., ... & Wagar, L. E. (2025). Human CD4 T cells are a functional target for lipid nanoparticle-based mRNA vaccines. mBio, e02254-25.
    https://journals.asm.org/doi/full/10.1128/mbio.02254-25
  53. Ko, K. H., Lee, S. H., Choi, Y. H., Kang, S. M., Yang, H. S., Lee, S. M., ... & Cha, S. B. (2025). Lipid nanoparticle encapsulated TLR3 agonist adjuvant elicits potent T cell immunity against cancer and viruses. npj Vaccines.
    https://www.nature.com/articles/s41541-025-01349-w
  54. Kukushkin, I., Vasileva, O., Kunyk, D., Kolmykov, S., Sokolova, T., Muslimov, A., ... & Reshetnikov, V. (2024). Effects of Various Poly (A) Tails on Luciferase Expression. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 18(3), 263-274.
    https://link.springer.com/article/10.1134/S1990750824600055
  55. Lee, Y., Park, J. S., Jeon, H., Lim, S. G., Lee, D., & Koo, H. (2025). Lung-targeted delivery of TRAIL and BAK mRNA by optimized lipid nanoparticles for in vivo lung metastasis. Chemical Engineering Journal, 167379.
    https://www.sciencedirect.com/science/article/abs/pii/S138589472508218X
  56. Lewis, M. M., Beck, T. J., & Ghosh, D. (2023). Applying machine learning to identify ionizable lipids for nanoparticle-mediated delivery of mRNA. bioRxiv, 2023-11.
    https://doi.org/10.1101/2023.11.09.565872
  57. Li, R.; Luozhong, S.; Gu, W.; Kim, A.; Liu, D.; Hu, Y.; Cui, M.; Lian, F.; Cao, Z.; Zhao, Y.; McIlhenny, K.; Ma, Y.; Chan, A.; Zhang, P.; Wang, J.; Jiang, S. Glycan Chemical Structures Dictate Organ- and Cell-Specific Tropism and Immunomodulation of Lipid Nanoparticles. ACS Nano 2026, 20 (16), 12551–12564.
    https://doi.org/10.1021/acsnano.6c01073
  58. Li, Y., Ambati, S., Meagher, R. B., & Lin, X. (2025). Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model. npj Vaccines, 10(1), 24.
    https://www.nature.com/articles/s41541-025-01079-z
  59. Lim, H.; Jung, H.; Jeon, H.-G.; Heo, S.; Lee, S.; Lee, E.; Choi, J. S.; Kim, Y.; Yang, J. Impact of Clinically Approved Ionizable Lipids on the Immunogenic Response of Varicella Zoster Virus Glycoprotein E MRNA-LNP Vaccines. 2026.
    https://doi.org/10.2139/ssrn.6056385
  60. Lindsay, S., Hussain, M., Binici, B., & Perrie, Y. (2025). Exploring the challenges of lipid nanoparticle development: the in vitro–in vivo correlation gap. Vaccines, 13(4), 339.
    https://www.mdpi.com/2076-393X/13/4/339
  61. Ma, Y., Fung, V., VanKeulen-Miller, R., Tiwade, P. B., Narasipura, E. A., Gill, N. A., & Fenton, O. S. (2025). A Metabolite Co-Delivery Strategy to Improve mRNA Lipid Nanoparticle Delivery. ACS Applied Materials & Interfaces, 17(18), 26202-26215.
    https://pubs.acs.org/doi/abs/10.1021/acsami.4c22969
  62. Ma, Y., VanKeulen-Miller, R., & Fenton, O. S. (2025). mRNA lipid nanoparticle formulation, characterization and evaluation. Nature Protocols, 1-34.
    https://www.nature.com/articles/s41596-024-01134-4
  63. Macfarlane, R.; Binici, B.; Hussain, M.; Borah, A.; Wheeler, L.; Wilkinson, M.; Orr, N.; Clarke, S.; Perrie, Y. IVIS Assessment of mRNA-LNP Protein Expression: Effects of Dosing Parameters and Prior LNP Exposure. International Journal of Pharmaceutics 2027, 706, 127567.
    https://doi.org/10.1016/j.ijpharm.2026.127567
  64. Mae LEWIS, Debadyuti GHOSH. Aerosolized lipid nanoparticles and uses thereof. (WO2024107702A1)
    https://patents.google.com/patent/WO2024107702A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=17
  65. Maslanka, J. R.; She, Q.; Krauss, K. S.; Konopka, E. N.; Bayard, N. U.; Londregan, J.; Alameh, M.-G.; Eisenlohr, L. C.; Kutzler, M. A.; Zackular, J. P.; Abt, M. C. Generation and Characterization of a Novel MHC-II Tetramer for Tracking and Characterization of Toxin B-Specific CD4 + T Cell Responses. 2026.
    https://doi.org/10.64898/2026.02.18.706639
  66. McMillan, C., Druschitz, A., Rumbelow, S., Borah, A., Binici, B., Rattray, Z., & Perrie, Y. (2024). Tailoring lipid nanoparticle dimensions through manufacturing processes. RSC pharmaceutics.
    https://pubs.rsc.org/en/content/articlehtml/2024/pm/d4pm00128a
  67. Meany, E. L., Klich, J. H., Jons, C. K., Mao, T., Chaudhary, N., Utz, A., ... & Appel, E. (2024). Generation of an inflammatory niche in an injectable hydrogel depot through recruitment of key immune cells improves efficacy of mRNA vaccines. bioRxiv, 2024-07.
    https://doi.org/10.1101/2024.07.05.602305
  68. Meany, E. L., Klich, J. H., Jons, C. K., Mao, T., Chaudhary, N., Utz, A., ... & Appel, E. (2025). Generation of an inflammatory niche in a hydrogel depot through recruitment of key immune cells improves efficacy of mRNA vaccines. Science Advances, 11(15), eadr2631.
    https://www.science.org/doi/full/10.1126/sciadv.adr2631
  69. Meulewaeter, S., Aernout, I., Deprez, J., Engelen, Y., De Velder, M., Franceschini, L., ... & Lentacker, I. (2024). Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria. Journal of Controlled Release, 370, 379-391.
    https://www.sciencedirect.com/science/article/pii/S0168365924002815
  70. Narasipura, E. A.; Fung, V.; VanKeulen‐Miller, R.; Tiwade, P. B.; Fenton, O. S. CORE: Cholesterol Altered Lipid Nanoparticles for Splenic Expression of MRNA Payloads. Advanced Healthcare Materials 2026.
    https://doi.org/10.1002/adhm.202505862
  71. Ogawa, K., Aikawa, O., Tagami, T., Ito, T., Tahara, K., Kawakami, S., & Ozeki, T. (2024). Stable and inhalable powder formulation of mRNA-LNPs using pH-modified spray-freeze drying. International Journal of Pharmaceutics, 124632.
    https://www.sciencedirect.com/science/article/abs/pii/S0378517324008664
  72. Ogawa, K., Tagami, T., Miyake, S., & Ozeki, T. (2025). Choice of organic solvent affects function of mRNA-LNP; pyridine produces highly functional mRNA-LNP. International Journal of Pharmaceutics, 673, 125367.
    https://doi.org/10.1016/j.ijpharm.2025.125367
  73. Owen FENTON, Yutian MA, Palas TIWADE.Compositions and methods for delivering cargo to cells. (WO2024216026A1)
    https://patents.google.com/patent/WO2024216026A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=13
  74. Owen FENTON, Yutian MA. Polyphenol lipid nanoparticles and methods of use. (WO2024107938A2)
    https://patents.google.com/patent/WO2024107938A2/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=17
  75. Owen Shea Fenton, Eshan Amruth NARASIPURA. Cholesterol derivatives and methods of use. (WO2025014916A1)
    https://patents.google.com/patent/WO2025014916A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=11
  76. Owen Shea Fenton, Yutian MA, Rachel VANKEULEN-MILLER. Approaches for optimization and discovery of nanoparticles and uses thereof. (WO2025178896A1)
    https://patents.google.com/patent/WO2025178896A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=2
  77. Owen Shea Fenton, Yutian MA. Vectors for nucleic acid delivery. (WO2024220665A1)
    https://patents.google.com/patent/WO2024220665A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=13
  78. Park, D.; Lee, B.; Ma, J.-H.; Kim, Y.; Hwang, J. S.; Lee, H. W.; Yoo, M. H.; Kim, U.-K.; Kwon, T.-J. Exploration of Biodistribution of mRNA-Delivering Lipid Nanoparticles in the Neonatal Mouse Inner Ear. International Journal of Pharmaceutics: X 2026, 12, 100675.
    https://doi.org/10.1016/j.ijpx.2026.100675
  79. Park, D.; Lee, B.; Ma, J.-H.; Kim, Y.; Hwang, J. S.; Lee, H. W.; Yoo, M. H.; Kim, U.-K.; Kwon, T.-J. Exploration of Biodistribution of mRNA-Delivering Lipid Nanoparticles in the Neonatal Mouse Inner Ear. International Journal of Pharmaceutics: X 2026, 12, 100675.
    https://doi.org/10.1016/j.ijpx.2026.100675
  80. Park, J. S.; Jeon, H.; Lee, Y.; Seong Gi, L.; Seo Young, C.; Kim, I.-B.; Choi, H.; Koo, H. Accelerated Chondrogenic Differentiation of Stem Cells by SOX9 mRNA/Dexamethasone-Co-Loaded Lipid Nanoparticle for Efficient Cartilage Repair. Chemical Engineering Journal 2026, 547, 181085.
    https://doi.org/10.1016/j.cej.2026.181085
  81. Qin, Jane, Ju Hyeong Jeon, Jiangsheng Xu, Laura Katherine Langston, Ramesh Marasini, Stephanie Mou, Brian Montoya et al. Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccine. Frontiers in Immunology. 2023
    https://www.researchgate.net/profile/Ramesh-Marasini/publication/369688271_Design_and_preclinical_evaluation_of_a_universal_SARS-CoV-2_mRNA_vaccine/links/642786ee315dfb4ccec16ec4/Design-and-preclinical-evaluation-of-a-universal-SARS-CoV-2-mRNA-vaccine.pdf
  82. Rochman, Y., Kotliar, M., Klingler, A. M., Rochman, M., Alameh, M. G., Melamed, J. R., ... & Rothenberg, M. E. (2025). Allergen-specific mRNA–lipid nanoparticle therapy for prevention and treatment of experimental allergy in mice. The Journal of Clinical Investigation, 135(21).
    https://www.jci.org/articles/view/194080
  83. Ruppl, A., Kiesewetter, D., Koell-Weber, M., Lemazurier, T., Süss, R., & Allmendinger, A. (2025). Formulation screening of lyophilized mRNA-lipid nanoparticles. International Journal of Pharmaceutics, 125272.
    https://www.sciencedirect.com/science/article/pii/S0378517325001085
  84. Ruppl, A., Kiesewetter, D., Strütt, F., Köll-Weber, M., Süss, R., & Allmendinger, A. (2024). Don’t shake it! Mechanical stress testing of mRNA-lipid nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics, 198, 114265.
    https://www.sciencedirect.com/science/article/pii/S0939641124000912
  85. Sakers, S. H., Fiduccia, G., Byrne, K. E., Reddy, B. P. K., Dahlman, J. E., & Prausnitz, M. R. (2025). The effect of mRNA-lipid nanoparticle composition on stability during microneedle patch manufacturing. European Journal of Pharmaceutics and Biopharmaceutics, 114819.
    https://www.sciencedirect.com/science/article/pii/S0939641125001961
  86. Sakers, S. H., Reddy, B. P. K., Fiduccia, G., Byrne, K. E., Stén, I., Kim, J., ... & Prausnitz, M. R. (2025). Development of a microneedle patch for delivery of mRNA-lipid nanoparticles. Drug Delivery and Translational Research, 1-16.
    https://link.springer.com/article/10.1007/s13346-025-01964-z
  87. Saraswat, A., Vemana, H. P., Dukhande, V., & Patel, K. (2024). Novel gene therapy for drug-resistant melanoma: Synergistic combination of PTEN plasmid and BRD4 PROTAC-loaded lipid nanocarriers. Molecular Therapy-Nucleic Acids, 35(3).
    https://www.cell.com/molecular-therapy-family/nucleic-acids/fulltext/S2162-2531(24)00179-3
  88. Saraswat, Aishwarya, and Ketan Patel. Delineating effect of cationic head group and preparation method on transfection versus toxicity of lipid-based nanoparticles for gene delivery. PREPRINT. 2023
    https://www.researchsquare.com/article/rs-2649244/v1
  89. Shah, N., Soma, S. R., Quaye, M. B., Mahmoud, D., Ahmed, S., Malkoochi, A., & Obaid, G. (2024). A Physiochemical, In Vitro, and In Vivo Comparative Analysis of Verteporfin–Lipid Conjugate Formulations: Solid Lipid Nanoparticles and Liposomes. ACS Applied Bio Materials.
    https://pubs.acs.org/doi/full/10.1021/acsabm.4c00316
  90. Shah, S., Ranasinghe, M., Decker, J., Fraser, K., Friedman, A., Wang, Y., ... & Yao, S. (2025). Lipid Nanoparticles with Aptamers Enable Targeted mRNA Delivery to CD4⁺ T Cells. bioRxiv, 2025-09.
    https://www.biorxiv.org/content/10.1101/2025.09.10.675359v1.full
  91. Shin, J. E., Won, E. J., Xu, J., Lee, J. C., Bang, J. K., Mitchell, M. J., & Cha-Molstad, H. (2025). Transition temperature-guided design of lipid nanoparticles for effective mRNA delivery. ACS Applied Materials & Interfaces, 17(19), 28012-28024.
    https://pubs.acs.org/doi/full/10.1021/acsami.5c06464
  92. Shinkai, T., Ogawa, K., Tagami, T., & Ozeki, T. (2024). Cholic acid-mediated targeting of mRNA-LNPs improve the mRNA delivery to Caco-2 cells. Journal of Nanoparticle Research, 26(11), 1-12.
    https://link.springer.com/article/10.1007/s11051-024-06161-6
  93. Shinkai, T.; Ogawa, K.; Mohamed, M. S.; Ozeki, T. Comprehensive Evaluation of Gastrointestinal Factors Influencing the Stability and Function of mRNA‐Encapsulated Lipid Nanoparticles. Drug Development Research 2026, 87 (7).
    https://doi.org/10.1002/ddr.70392
  94. Shkodra, B., Muglikar, A., Thangapandian, J., Schumacher, M., Binici, B., & Perrie, Y. (2025). Boosting LNP performance: higher concentrations of lipid mixtures improve in vivo gene expression and storage stability. Pharmaceutics, 18(1), 50.
    https://www.mdpi.com/1999-4923/18/1/50
  95. Shyh-Dar Li, Ramya KANNAN, Quan Li, Feng Zhao, Binh Tran, Jiamin Wu, Pei Jen Angel LEE. Polymers for enhancing lipid nanoparticle delivery of nucleic acids. (WO2025207986A1)
    https://patents.google.com/patent/WO2025207986A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=1
  96. Spiewla, T., Czubak, K., Pilch, Z., Baranowski, M. R., Krawczyk, P. S., Affek, K., ... & Kowalska, J. (2025). PolyA tail segmentation improves the stability of the template DNA and increases the translatability of in vitro transcribed mRNA. bioRxiv, 2025-10.
    https://www.biorxiv.org/content/10.1101/2025.10.21.683660v1.full
  97. Stephan, S. B.; Cummings, C. L.; Fitzgerald, K.; Stephan, M. T. Drinkable Gene Therapy Foam for the Treatment of Constrictive Esophageal Carcinoma. Gene Therapy 2026.
    https://doi.org/10.1038/s41434-026-00592-7
  98. Stephanie, F.; Hussain, M.; Evdokimou, M.; Parkinson, J.; Perrie, Y.; coxon. Structure–Function Relationships of Ionisable Lipids: Headgroup-Driven Changes in Lipid Nanoparticle Architecture and mRNA Delivery Outcomes, 2026.
    https://doi.org/10.2139/ssrn.7434569
  99. Tatsuno, K., Vassall, A., Hanlon, D., Pitruzzello, M., Robinson, E., Sobolev, O., ... & Edelson, R. (2025). An anti-cancer cell therapy platform utilizing ex vivo physiologic dendritic cells expressing mRNA-encoded antigens and immune checkpoint blockers.
    https://www.researchsquare.com/article/rs-6480245/v1
  100. VanKeulen-Miller, R., Huff, J., Narasipura, E. A., Browne, E. P., & Fenton, O. S. (2025). Customizable mRNA Lipid Nanoparticles for Transfection of Primary Human T Cells. ACS nano.
    https://pubs.acs.org/doi/full/10.1021/acsnano.5c15903
  101. Warminski, M., Depaix, A., Ziemkiewicz, K., Spiewla, T., Zuberek, J., Drazkowska, K., ... & Jemielity, J. (2024). Trinucleotide cap analogs with triphosphate chain modifications: synthesis, properties, and evaluation as mRNA capping reagents. Nucleic Acids Research, gkae763.
    https://academic.oup.com/nar/advance-article/doi/10.1093/nar/gkae763/7753433
  102. Wei, C., Zhu, Y., Lu, X., Goodier, K. D., Yu, D., Liu, X., ... & Mao, H. Q. (2025). Systemic trafficking of mRNA lipid nanoparticle vaccine following intramuscular injection generates potent tissue-specific T cell response. bioRxiv, 2025-04.
    https://doi.org/10.1101/2025.04.21.649878
  103. Wei, C., Zhu, Y., Lu, X., Goodier, K. D., Yu, D., Liu, X., ... & Mao, H. Q. (2025). Systemic trafficking of mRNA lipid nanoparticle vaccine following intramuscular injection generates potent tissue-specific T cell response. bioRxiv, 2025-04.
    https://www.biorxiv.org/content/10.1101/2025.04.21.649878v1.full
  104. Wisdom, A. J.; Rogers, Z. J.; Chatterjee, F.; Cui, Y.; Garcia-Rivera, L.; Temple, H.; Abdelfattah, N. S.; Coombs, T.; Van, R.; Tafuri Del Vecchio, C.; So, H. K.; Heim, T. A.; Wolczanski, G.; Mount, C. W.; Butty, V. L.; Levine, S. S.; Cormier, K.; Love, J. C.; Kaech, S. M.; Jacks, T.; White, F. M.; Spranger, S. Radiation Therapy Synergizes With mRNA Vaccination to Overcome Microglia-Mediated Suppression of Dendritic Cell Migration and T Cell Priming in Glioblastoma. 2026.
    https://doi.org/10.64898/2026.09.18.752741
  105. Yen-Chun LU, Timothy Kosarick EITAS, Nicholas Edward JONES, Leon Brown, Hao Chen, Md Munan SHAIK, Ronnie R. Wei, John R. Mascola, Elias A. Zerhouni, Gary J. Nabel, Zhi-Yong Yang, Lan Wu, Sian LIAO, Elissa Kathleen Leonard, Mohui WEI. Targeted lnp delivery. (US20250161481A1)
    https://patents.google.com/patent/US20250161481A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=5
  106. Zahedipour, F.; Sadeghianfard, S.; Wisser, S.; Dinarvand, M.; Steiner, D.; Ramesh, A.; Trosien, P.; Leibold, J.; Mezger, M.; Mohammadian Gol, T. Lipid Nanoparticle Delivery of CAR276 mRNA Enables Antigen-Specific Cytotoxicity in T Cells Against Glioblastoma Cells. Biomedicines 2026, 14 (10), 2365.
    https://doi.org/10.3390/biomedicines14102365
  107. Zhang, J.; Hołubowicz, R.; Smidak, R.; Hu, Y.; Du, S. W.; Felgner, J. H.; Palczewska, G.; Rodrigues Menezes, C.; Risaliti, E.; Dong, Z.; Ma, X.; Shayegan, M. H.; Chen, P. Z.; Xing, L.; Hołubowicz, M.; Li, B.; Liu, D. R.; Felgner, P. L.; Tochtrop, G. P.; Palczewski, K. A Combinatorial Synthetic Strategy for Developing Genome-Editing Protein-Delivery Agents Targeting Mouse Retina. Nature Communications 2026, 17 (1).
    https://doi.org/10.1038/s41467-026-69077-w
  108. Zhao, F., Luppi, B., Chao, P. H., Yang, J., Zhang, Y., Feng, R., ... & Li, S. D. (2026). Biodegradable polymers with tertiary amines enhance mRNA delivery of lipid nanoparticles via improved endosomal escape. Biomaterials, 324, 123541.
    https://www.sciencedirect.com/science/article/abs/pii/S0142961225004600
  109. Zhu, Y.; Miao, Y.; Anderson, I. J.; Li, Y.; Aghnatios, B.; No, J.; Ma, J.; Yu, Di; Wei, C.; Lu, X.; Wang, J.; van de Klashorst, J.; Mao, H.-Q.; Hickey, J. W. Spatial Profiling of Pooled mRNA-LNP Delivery in Vivo With NanoSTAMP. 2026.
    https://doi.org/10.64898/2026.08.25.746710
  110. 昂輝 小川, 辰秋 田上, 哲也 尾関, 慧 三宅. Nucleic acid-encapsulating lipid nanoparticle production method. (WO2025164564A1)
    https://patents.google.com/patent/WO2025164564A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=3
  111. 杨水祥, 杨冰漪, 闫娟. Preparation of SARS-Cov-2 mRNA universal vaccine. (CN116808190A)
    https://patents.google.com/patent/CN116808190A/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=21
  112. 김윤경, 전해근, 정혜연, 호베트그응, 이지윤. Lipid compound and composition for delivery of active substance. (WO2024106781A1)
    https://patents.google.com/patent/WO2024106781A1/en?q=(BROADPHARM)&oq=BROADPHARM&sort=new&page=18